Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA. View Finnegan
analysis. Venue: Federal Circuit. Case. 13-1406. Judges: Prost (author), Plager,
with the best user experience. By accepting cookies, you agree to our use of
Plaintiff brought a qui tam action against Takeda Pharmaceutical Company and
its affiliates (collectively, Takeda) and Eli Lilly and Company (Eli Lilly) (
collectively, Defendants) under the False Claims Act (FCA) and the False Claims
Acts of several different states, alleging that Defendants engaged in an illegal
TAKEDA PHARMACEUTICAL CO. v. ZYDUS PHARMACEUTICALS. USA. 3.
SoluTab™. Takeda then filed suit, alleging that Zydus's. ANDA product infringed
multiple claims of several pa- tents. Only claim 1 of the '994 patent remains at
issue. Zydus counterclaimed, alleging that claim 1 was invalid for failure to
comply with ...
Feb 20, 2014 ... Case Opinion For US Federal Circuit TAKEDA PHARMACEUTICAL COMPANY
LIMITED LLC v. ZYDUS PHARMACEUTICALS USA INC. Read the Court's full
decision on FindLaw.